Levodopa, the gold-standard treatment for Parkinson’s disease, is often given alongside medicines called catechol-O-methyltransferase inhibitors (COMT-Is) that are designed…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
A new support group called Angels Embrace aims to offer education, connection, and emotional support for people affected by neurodegenerative…
In the U.S., the total cost of Parkinson’s disease — including direct medical costs and lost productivity from patients and…
Scientists have demonstrated that it is possible to collect individualized data on how connections among brain circuits change for people…
Scientists in Denmark are embarking on a three-year project aiming to develop a…
The first few participants in a clinical trial have reported notable easing of motor symptoms following treatment with Oryon Cell…
Regulators in the U.S. and China have granted Xellsmart permission to start clinical testing of its experimental stem cell…
People with Parkinson’s disease have altered levels of certain metals, including iron, in their hair, according to a new study.
Breathing carbon dioxide (CO2) for brief periods may help activate the brain’s natural cleanup systems that remove toxic proteins in…
Throughout 2025, the team at Parkinson’s News Today has reported on the latest research updates and advances in care related…